ACAD

7
Acadia pharmaceuticals
Stock :NASDAQ
: Healthcare
: Biotechnology
Miracle Viewer
  08/12/2022 22:00 GMT+2
3.12
15.65719
14.42656
-0.829
0.013
0.015
-0.031

Ruota il tuo smartphone per vedere un grafico migliore
Ruota il tuo smartphone per vedere un grafico migliore

Operativity type

LONG
Profit %
86.23 %
Timeframe
H 1
Duration
11
ACAD
Sector: Health Technology
Industry: Biotechnology
Employees: 601

ACADIA Pharmaceuticals, Inc. operates as a biopharmaceutical company.

It focuses on the development and commercialization of medicines to address unmet medical needs in central nervous system, or CNS, disorders.

The firm's products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis.

The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.